{"filing":{"accession_number":"0001493152-26-044432","cik":"0001583771","ticker":"CTRVP","company_name":"Hepion Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-09-28","report_date":"2026-09-21","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315226044432/form8-k.htm"},"events":[{"id":35267,"run_id":32479,"accession_number":"0001493152-26-044432","anchor_item_number":"4.01","event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"The filing discloses the dismissal of Grassi \u0026 Co., CPAs, P.C. as the Company's independent registered public accounting firm and the engagement of Rosenberg Rich Baker Berman P.A. as the new auditor, effective September 22, 2026. This is a classic auditor change under Item 4.01. While the prior auditor's reports contained an explanatory paragraph noting substantial doubt about going concern, the core event disclosed is the change in auditors itself, which is material to investors' assessment of financial reporting oversight.","company_name":"Hepion Pharmaceuticals, Inc.","ticker":"CTRVP","filing_date":"2026-09-28","form":"8-K","submitted_at":null,"items":[{"id":39260,"accession_number":"0001493152-26-044432","item_number":"4.01","item_title":null,"event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the dismissal of Grassi \u0026 Co., CPAs, P.C. as the Company's independent registered public accounting firm and the engagement of Rosenberg Rich Baker Berman P.A. as the new auditor, effective September 22, 2026. This is a classic auditor change under Item 4.01. While the prior auditor's reports contained an explanatory paragraph noting substantial doubt about going concern, the core event disclosed is the change in auditors itself, which is material to investors' assessment of financial reporting oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T10:34:54.131137+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39260,"accession_number":"0001493152-26-044432","item_number":"4.01","item_title":null,"event_type":"auditor_change","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the dismissal of Grassi \u0026 Co., CPAs, P.C. as the Company's independent registered public accounting firm and the engagement of Rosenberg Rich Baker Berman P.A. as the new auditor, effective September 22, 2026. This is a classic auditor change under Item 4.01. While the prior auditor's reports contained an explanatory paragraph noting substantial doubt about going concern, the core event disclosed is the change in auditors itself, which is material to investors' assessment of financial reporting oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T10:34:54.131137+00:00","company_name":"Hepion Pharmaceuticals, Inc.","ticker":"CTRVP","filing_date":"2026-09-28"}]}